Lara Mittereder - Concepedia

Author

Lara Mittereder

National Institutes of Health ORCID

Also Known As

Lara Mittereder, Lara R Mittereder, Lara R. Mittereder

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Allergy and Infectious Diseases Center for Biologics Evaluation and Research National Cancer Institute United States Food and Drug Administration

About

Lara Mittereder is an author at National Institutes of Health specializing in immunology, medicine, and t cell immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	118
2	Immunology	4	4	118
3	Allergy	3	3	108
4	Cell Biology	1	1	78
5	Microbiology	1	1	18

Lara Mittereder

Publications

Citations

H-Index

Page 1

	Year	Citations
A major role for ferroptosis in <i>Mycobacterium tuberculosis</i>–induced cell death and tissue necrosis Eduardo P. Amaral, Diego L. Costa, Sivaranjani Namasivayam, The Journal of Experimental Medicine	2019	433
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy Sivaranjani Namasivayam, Mamoudou Maïga, Wuxing Yuan, Microbiome	2017	145
The IL-12 Response of Primary Human Dendritic Cells and Monocytes to <i>Toxoplasma gondii</i> Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion Kevin Tosh, Lara Mittereder, Sandra Bonne-Année, The Journal of Immunology Cellular ImmunologyImmune RegulationImmunologyInnate Immune SystemImmunologic Mechanism	2015	78
Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection <i>In Vivo</i> by a Mechanism Dependent on T Lymphocytes Diego L. Costa, Sivaranjani Namasivayam, Eduardo P. Amaral, mBio	2016	53
Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques Sivaranjani Namasivayam, Keith D. Kauffman, John A. McCulloch, mBio	2019	53
Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway Nicolas Riteau, Andrea J. Radtke, Kevin Shenderov, The Journal of Immunology	2016	46
Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis Caio César Barbosa Bomfim, Logan Fisher, Eduardo P. Amaral, Frontiers in Cellular and Infection Microbiology	2022	46
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer Christina N. Bennett, Christine C. Tomlinson, Aleksandra M. Michalowski, Breast Cancer Research	2012	33
Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection Diego L. Costa, Eduardo P. Amaral, Sivaranjani Namasivayam, Mucosal Immunology	2020	33
A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis Roberto De Pascalis, Andrew C. Hahn, Helen M. Brook, PLoS ONE	2018	21

Page 1